p.4 抽出テキスト

9.5.1.3.1. Influenza virus .................................................................. 4004 9.5.1.3.2. Human immunodeficiency virus .............................. 4004 9.5.2. Lyme carditis ..................................................................................... 4004 9.5.2.1. Presentation ............................................................................. 4004 9.5.2.2. Diagnosis .................................................................................... 4004 9.5.2.3. Therapy ...................................................................................... 4004 9.5.3. Chagas disease ................................................................................. 4005 9.5.3.1. Presentation ............................................................................. 4005 9.5.3.2. Diagnosis .................................................................................... 4005 9.5.3.3. Therapy ...................................................................................... 4005 9.6. Drug- or vaccine-induced myocarditis .......................................... 4005 9.6.1. Drug-induced myocarditis ........................................................... 4005 9.6.1.1. Immune checkpoint inhibitor-induced myocarditis . 4005 9.6.1.1.1. Presentation ..................................................................... 4005 9.6.1.1.2. Diagnosis ........................................................................... 4005 9.6.1.1.3. Therapy .............................................................................. 4005 9.6.1.2. Other drugs associated with myocarditis .................... 4006 9.6.2. Vaccine-induced myocarditis ..................................................... 4006 9.7. Pregnancy-associated myocarditis ................................................... 4006 9.7.1. Presentation ...................................................................................... 4006 9.7.2. Diagnosis ............................................................................................ 4006 9.7.3. Therapy ............................................................................................... 4006 10. Inflammatory cardiomyopathy ................................................................ 4006 10.1. Presentation ........................................................................................... 4007 10.2. Diagnosis ................................................................................................. 4007 10.3. Therapy .................................................................................................... 4007 11. Specific types of pericarditis ..................................................................... 4007 11.1. Tuberculous pericarditis ................................................................... 4007 11.1.1. Presentation ................................................................................... 4007 11.1.2. Diagnosis .......................................................................................... 4007 11.1.3. Therapy ............................................................................................ 4008 11.2. Pericardial involvement in neoplastic disease .......................... 4009 11.2.1. Presentation ................................................................................... 4009 11.2.2. Diagnosis .......................................................................................... 4009 11.2.3. Therapy ............................................................................................ 4009 11.3. Post-cardiac injury syndrome ......................................................... 4009 11.3.1. Diagnosis .......................................................................................... 4010 11.3.2. Therapy ............................................................................................ 4010 11.4. Pericarditis and autoinflammatory diseases ............................. 4010 11.5. Purulent pericarditis ........................................................................... 4010 11.5.1. Presentation ................................................................................... 4011 11.5.2. Diagnosis .......................................................................................... 4011 11.5.3. Therapy ............................................................................................ 4011 11.6. Incessant and recurrent pericarditis ............................................ 4011 11.7. Inflammatory and non-inflammatory pericardial effusion .. 4011 11.7.1. Classification and aetiology ...................................................... 4011 11.7.2. Presentation ................................................................................... 4011 11.7.3. Diagnosis .......................................................................................... 4012 11.7.4. Therapy ............................................................................................ 4013 11.7.5. Prognosis and follow-up ........................................................... 4013 11.8. Cardiac tamponade ............................................................................. 4013 11.8.1. Presentation ................................................................................... 4013 11.8.2. Aetiology and diagnosis ............................................................. 4013 11.8.3. Therapy ............................................................................................ 4014 11.8.4. Outcomes and prognosis ......................................................... 4014 11.9. Pericardial constriction and constrictive pericarditis (calcified and non-calcified) ......................................................................... 4014 11.9.1. Introduction .................................................................................... 4014 11.9.2. Presentation ................................................................................... 4014 11.9.3. Diagnosis .......................................................................................... 4014 11.9.4. Therapy ............................................................................................ 4015 11.10. Effusive–constrictive pericarditis ................................................ 4015 11.10.1. Introduction ................................................................................. 4015 11.10.2. Aetiology ....................................................................................... 4015 11.10.3. Presentation ................................................................................. 4015 11.10.4. Diagnosis ....................................................................................... 4015 11.10.5. Treatment ..................................................................................... 4015 12. Age- and sex-related aspects in inflammatory myopericardial syndrome .................................................................................................................. 4015

12.1. Sex distribution ..................................................................................... 4015 12.2. Paediatric patients ............................................................................... 4016 12.2.1. Myocarditis ...................................................................................... 4016 12.2.2. Pericarditis ....................................................................................... 4016 12.3. Pregnancy, lactation, and reproductive issues ......................... 4016 12.4. The elderly .............................................................................................. 4017 12.5. Physical activity in inflammatory myopericardial syndrome 4017 12.5.1. Mental health effect of restricting exercise ...................... 4017 12.6. Multidisciplinary teams for the management of inflammatory myopericardial syndrome ............................................................................ 4017 13. Advice for patients ....................................................................................... 4018 14. Tertiary referral centres for inflammatory myopericardial syndrome: feature and volume of activity .................................................. 4018 14.1. Tertiary care centres .......................................................................... 4018 14.2. Inflammatory myopericardial syndrome in regional centres 4018 14.3. Hub-and-spoke model ....................................................................... 4018 14.4. Teamwork, competencies, and advances in imaging techniques .......................................................................................................... 4019 15. Key messages .................................................................................................. 4019 15.1. Aetiology ................................................................................................. 4019 15.2. Clinical presentation and diagnosis .............................................. 4019 15.3. Therapy .................................................................................................... 4019 15.4. Prognosis and outcomes .................................................................. 4019 15.5. Multidisciplinary team ........................................................................ 4019 16. Gaps in evidence ............................................................................................ 4019 16.1. Myocarditis ............................................................................................. 4019 16.2. Pericarditis .............................................................................................. 4020 17. Sex differences ............................................................................................... 4020 18. ‘What to do’ and ‘What not to do’ messages from the Guidelines ................................................................................................................. 4020 19. Evidence tables ............................................................................................... 4023 20. Data availability statement ......................................................................... 4023 21. Author information ...................................................................................... 4023 22. Appendix ........................................................................................................... 4024 ESC Scientific Document Group ................................................................... 4024 23. References ........................................................................................................ 4025

Tables of Recommendations Recommendation Table 1 — Recommendations for clinical evaluation of myocarditis and pericarditis (see Evidence Table 1) . 3979 Recommendation Table 2 — Recommendations for genetic testing (see Evidence Table 2) ........................................................................................ 3981 Recommendation Table 3 — Recommendations for the use of cardiovascular magnetic resonance imaging (see Evidence Table 3) 3983

ESC Guidelines                                                                                                                                                                                          3955

Downloaded from academic.oup.com/eurheartj/article/46/40/3952/8234483 by guest on 07 October 2026